We are live on ! Find out more
FO

FT Options Portfolio holdings

AUM $66.4M
1-Year Est. Return 18.48%
This Fund
S&P 500
This Quarter Est. Return
+24.92%
1 Year Est. Return
+18.48%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$126M
AUM Growth
+$9.73M
Cap. Flow
-$2.73M
Cap. Flow %
-2.16%
Top 10 Hldgs %
37.67%
Holding
493
New
153
Increased
113
Reduced
67
Closed
127

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$3.82M
2
BMY icon
Bristol-Myers Squibb
BMY
+$2.47M
3
IBB icon
iShares Biotechnology ETF
IBB
+$2M
4
ULTA icon
Ulta Beauty
ULTA
+$1.86M
5
MON
Monsanto Co
MON
+$1.82M

Top Sells

Rank Stock Value
1
MDVN
MEDIVATION, INC.
MDVN
+$7.18M
2
BIIB icon
Biogen
BIIB
+$4.33M
3
CALM icon
Cal-Maine
CALM
+$3.64M
4
AAPL icon
Apple
AAPL
+$2.74M
5
ALR
Alere Inc
ALR
+$2.22M

Sector Composition

Rank Sector Weight
1 Healthcare 42.49%
2 Miscellaneous 37.27%
3 Consumer Staples 5.72%
4 Consumer Discretionary 5.23%
5 Technology 3.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
26
Gilead Sciences
GILD
$187B
$1.3M 1.03%
16,421
+11,531
+236% +$937K
WMT icon
27
Walmart Inc
WMT
$850B
$1.28M 1.02%
+53,313
New +$1.29M
UTHR icon
28
United Therapeutics
UTHR
$20.9B
$1.25M 0.99%
+10,566
New +$1.27M
PG icon
29
PUT
Procter & Gamble
PG
$340B
$1.23M 0.98%
61,500
+46,500
+310% +$4.04M
KITE
30
DELISTED
Kite Pharma, Inc.
KITE
$1.18M 0.94%
+21,134
New +$1.18M
SBUX icon
31
Starbucks
SBUX
$119B
$1.14M 0.91%
+21,100
New +$1.18M
CMRX
32
DELISTED
Chimerix, Inc.
CMRX
$1.14M 0.9%
205,266
-15,000
-7% -$68.7K
GIS icon
33
General Mills
GIS
$20.5B
$1.12M 0.89%
+17,506
New +$1.22M
SRPT icon
34
CALL
Sarepta Therapeutics
SRPT
$2.38B
$1.1M 0.87%
173,300
+129,800
+298% +$3.92M
ISRG icon
35
CALL
Intuitive Surgical
ISRG
$130B
$1.03M 0.82%
242,100
+147,600
+156% +$11.3M
FIVE icon
36
Five Below
FIVE
$13.9B
$1M 0.79%
24,830
+10,135
+69% +$469K
TJX icon
37
TJX Companies
TJX
$145B
$966K 0.77%
+25,828
New +$1.01M
OZK icon
38
Bank OZK
OZK
$5.5B
$909K 0.72%
23,675
+21,175
+847% +$803K
REGN icon
39
CALL
Regeneron Pharmaceuticals
REGN
$85.2B
$777K 0.62%
47,000
+21,500
+84% +$8.62M
AGN
40
DELISTED
Allergan plc
AGN
$764K 0.61%
3,316
-722
-18% -$176K
META icon
41
Meta Platforms (Facebook)
META
$1.57T
$744K 0.59%
+5,800
New +$720K
AAPL icon
42
CALL
Apple
AAPL
$4.67T
$691K 0.55%
194,400
+25,200
+15% +$667K
WWAV
43
CALL
DELISTED
The WhiteWave Foods Company
WWAV
$686K 0.54%
84,100
– –
BIIB icon
44
CALL
Biogen
BIIB
$32.6B
$678K 0.54%
28,300
-8,900
-24% -$2.64M
TSRO
45
PUT
DELISTED
TESARO, Inc.
TSRO
$650K 0.52%
111,300
-50,100
-31% -$4.68M
KO icon
46
Coca-Cola
KO
$379B
$633K 0.5%
+14,961
New +$656K
AERI
47
DELISTED
Aerie Pharmaceuticals
AERI
$628K 0.5%
+16,630
New +$367K
IBM icon
48
IBM
IBM
$221B
$623K 0.49%
4,106
+4,001
+3,810% +$607K
NXPI icon
49
CALL
NXP Semiconductors
NXPI
$57.5B
$610K 0.48%
+56,600
New +$4.8M
SAGE
50
DELISTED
Sage Therapeutics
SAGE
$588K 0.47%
12,778
+4,005
+46% +$163K
1
2
3 4 5

Similar funds

MC
Micawber Capital Seattle, Washington $62.9M AUM 20.32% 1-Year Est. Return
FIM
Friedberg Investment Management Houston, Texas $61.9M AUM 20.07% 1-Year Est. Return
TLIC
Thai Life Insurance Company Bangkok, Thailand $71M AUM 20.14% 1-Year Est. Return
MKCM
Mount Kellett Capital Management New York $61M AUM 12.22% 1-Year Est. Return
ACM
Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return
MFM
Marianas Fund Management New York $58.1M AUM 10.84% 1-Year Est. Return
VE
Vega Energy New York $75.5M AUM 15.36% 1-Year Est. Return
GFWEV
G.F.W. Energy VIII Irving, Texas $76.3M AUM 11.41% 1-Year Est. Return

FT Options's Q3 2016 Portfolio in Review

As of Q3 2016, FT Options held 493 positions worth $126M, up 8.4% from $116M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

FT Options's Q3 2016 filing shows 153 new, 113 increased, 67 reduced and 127 closed positions. Its largest new stake was iShares Biotechnology ETF: 21,000 shares worth $2.03M. The largest sale was MEDIVATION, INC., an estimated $7.18M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 41% a quarter earlier, followed by Miscellaneous and Consumer Staples.

  • FT Options's largest Q3 2016 buy was iShares Biotechnology ETF: 21,000 shares worth $2.03M.
  • FT Options added most to Procter & Gamble in Q3 2016, an estimated $3.82M increase.
  • FT Options's biggest Q3 2016 reduction was Apple, cutting an estimated $2.74M.
  • FT Options fully exited MEDIVATION, INC. in Q3 2016, selling an estimated $7.18M.
  • FT Options's ten largest holdings make up 38% of its $126M portfolio in Q3 2016.
  • FT Options opened 153 new positions and closed 127 in Q3 2016.
  • FT Options's portfolio value rose 8.4% quarter-over-quarter to $126M.

Based on FT Options's 13F filing for Q3 2016, filed 10 Nov 2016.